Relationship between cigarette use and prostate cancer risk: what do we know and what should we do?
Prostate Cancer and Prostatic Diseases, Published online: 22 April 2023; doi:10.1038/s41391-023-00671-5Relationship between cigarette use and prostate cancer risk: what do we know and what should we do? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 22, 2023 Category: Urology & Nephrology Authors: Jos é Ignacio Nolazco Lorelei A. Mucci Roman Sosnowski Krzysztof Przewo źniak Steven L. Chang Cosimo De Nunzio Source Type: research

The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery
Prostate Cancer and Prostatic Diseases, Published online: 21 April 2023; doi:10.1038/s41391-023-00672-4The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 21, 2023 Category: Urology & Nephrology Authors: Andrea Fuschi Antonio Luigi Pastore Yazan Al Salhi Alessia Martoccia Cosimo De Nunzio Giorgia Tema Onofrio Antonio Rera Flavia Carbone Anastasios D. Asimakopoulos Manfredi Bruno Sequi Fabio Maria Valenzi Paolo Pietro Suraci Silvio Scalzo Francesco Del Giu Source Type: research

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation
Prostate Cancer and Prostatic Diseases, Published online: 20 April 2023; doi:10.1038/s41391-023-00669-zAblative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 20, 2023 Category: Urology & Nephrology Authors: David-Dan Nguyen Tiange Li Roseanne Ferreira Mohamad Baker Berjaoui Anna-Lisa V. Nguyen Bilal Chughtai Kevin C. Zorn Naeem Bhojani Dean Elterman Source Type: research

Radiotheranostics in advanced prostate cancer: Current and future directions
Prostate Cancer and Prostatic Diseases, Published online: 14 April 2023; doi:10.1038/s41391-023-00670-6Radiotheranostics in advanced prostate cancer: Current and future directions (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 14, 2023 Category: Urology & Nephrology Authors: Angela Y. Jia Ana P. Kiess Qiubai Li Emmanuel S. Antonarakis Source Type: research

Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy
Prostate Cancer and Prostatic Diseases, Published online: 13 April 2023; doi:10.1038/s41391-023-00668-0Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 13, 2023 Category: Urology & Nephrology Authors: Luca Afferi Mattia Longoni Marco Moschini Giorgio Gandaglia Alicia K. Morgans Richard Cathomas Agostino Mattei Alberto Breda Roberto Mario Scarpa Rocco Papalia Cosimo de Nunzio Francesco Esperto Source Type: research

Prostate cancer metastasis and health disparities: a systematic review
Prostate Cancer and Prostatic Diseases, Published online: 12 April 2023; doi:10.1038/s41391-023-00667-1Prostate cancer metastasis and health disparities: a systematic review (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 12, 2023 Category: Urology & Nephrology Authors: Yusuf Liadi Taaliah Campbell Precious Dike Maxine Harlemon Bethtrice Elliott Valerie Odero-Marah Source Type: research

Correction to: The role of PSA density in the MRI pathway for prostate cancer diagnostics
Prostate Cancer and Prostatic Diseases, Published online: 03 April 2023; doi:10.1038/s41391-023-00664-4Correction to: The role of PSA density in the MRI pathway for prostate cancer diagnostics (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 3, 2023 Category: Urology & Nephrology Authors: Hannes Cash Martin Schostak Source Type: research

Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study
Prostate Cancer and Prostatic Diseases, Published online: 31 March 2023; doi:10.1038/s41391-023-00662-6Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 31, 2023 Category: Urology & Nephrology Authors: David Eldred-Evans Mathias Winkler Natalia Klimowska-Nassar Paula Burak Martin J. Connor Francesca Fiorentino Emily Day Derek Price Martin Gammon Henry Tam Heminder Sokhi Anwar R. Padhani Hashim U. Ahmed Source Type: research

Can high-intensity interval training impact tumor suppression and inflammatory response in prostate cancer survivors?
Prostate Cancer and Prostatic Diseases, Published online: 31 March 2023; doi:10.1038/s41391-023-00661-7Can high-intensity interval training impact tumor suppression and inflammatory response in prostate cancer survivors? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 31, 2023 Category: Urology & Nephrology Authors: Gillian Gresham Carolina Raines Arash Asher Stephen J. Freedland Celina H. Shirazipour Alix G. Sleight Source Type: research

Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men
Prostate Cancer and Prostatic Diseases, Published online: 27 March 2023; doi:10.1038/s41391-023-00660-8Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 27, 2023 Category: Urology & Nephrology Authors: Mohammad R. Siddiqui Eric V. Li Sai K. S. R. Kumar Anna Busza Jasmine S. Lin Ashorne K. Mahenthiran Jonathan A. Aguiar Parth V. Shah Brandon Ansbro Jordan M. Rich Soliman A. S. Moataz Mary-Kate Keeter Quan Mai Xinlei Mi Jeffrey J. Tosoian Edward M. Schaef Source Type: research

Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era
Prostate Cancer and Prostatic Diseases, Published online: 25 March 2023; doi:10.1038/s41391-023-00663-5Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 25, 2023 Category: Urology & Nephrology Authors: Ting Martin Ma Felix Y. Feng Seth A. Rosenthal Matthew B. Rettig Ann C. Raldow Daniel E. Spratt Michael Xiang Amar U. Kishan Source Type: research

Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 13 March 2023; doi:10.1038/s41391-023-00659-1Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 13, 2023 Category: Urology & Nephrology Authors: Jacob E. Tallman Christopher J. D. Wallis Li-Ching Huang Zhiguo Zhao David F. Penson Tatsuki Koyama Ralph Conwill Michael Goodman Ann S. Hamilton Xiao-Cheng Wu Lisa E. Paddock Antoinette Stroup Matthew R. Cooperberg Mia Hashibe Brock B. O ’Neil Sherrie Source Type: research

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 10 March 2023; doi:10.1038/s41391-023-00656-4Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 10, 2023 Category: Urology & Nephrology Authors: Mike Wenzel Luigi Nocera Claudia Coll à Ruvolo Christoph W ürnschimmel Zhe Tian Shahrokh F. Shariat Fred Saad Derya Tilki Markus Graefen Luis A. Kluth Alberto Briganti Philipp Mandel Francesco Montorsi Felix K. H. Chun Pierre I. Karakiewicz Source Type: research

Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 08 March 2023; doi:10.1038/s41391-023-00658-2Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 8, 2023 Category: Urology & Nephrology Authors: Jacob E. Tallman Christopher J. D. Wallis Zhiguo Zhao Li-Ching Huang David F. Penson Tatsuki Koyama Michael Goodman Ann S. Hamilton Xiao-Cheng Wu Lisa E. Paddock Antoinette Stroup Matthew R. Cooperberg Mia Hashibe Brock B. O ’Neil Sherrie H. Kaplan Shel Source Type: research

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging
Prostate Cancer and Prostatic Diseases, Published online: 06 March 2023; doi:10.1038/s41391-023-00657-3The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 6, 2023 Category: Urology & Nephrology Authors: Hae Lin Cho Subha Perni Anthony V. D ’Amico Kosj Yamoah Edward Christopher Dee Source Type: research